_version_ 1832591775763529728
author Alizée Bozonnat
Marie Beylot-Barry
Olivier Dereure
Michel D’Incan
Gaëlle Quereux
Emmanuella Guenova
Marie Perier-Muzet
Stephane Dalle
Florent Grange
Manuelle-Anne Viguier
Caroline Ram-Wolff
Laurence Feldmeyer
Helmut Beltraminelli
Nathalie Bonnet
Florent Amatore
Eve Maubec
Nathalie Franck
Laurent Machet
François Chasset
Florence Brunet-Possenti
Jean-David Bouaziz
Maxime Battistella
Marie Donzel
Anne Pham-Ledard
Claudia Bejar
Hélène Moins-Teisserenc
Samia Mourah
Philippe Saiag
Ewa Hainaut
Catherine Michel
Guido Bens
Henri Adamski
François Aubin
Serge Boulinguez
Pascal Joly
Billal Tedbirt
Isabelle Templier
Laura Troin
Henri Montaudié
Saskia Ingen-Housz-Oro
Sarah Faiz
Laurent Mortier
Gabor Dobos
Martine Bagot
Matthieu Resche-Rigon
Claire Montlahuc
Arnaud Serret-Larmande
Adèle de Masson
author_facet Alizée Bozonnat
Marie Beylot-Barry
Olivier Dereure
Michel D’Incan
Gaëlle Quereux
Emmanuella Guenova
Marie Perier-Muzet
Stephane Dalle
Florent Grange
Manuelle-Anne Viguier
Caroline Ram-Wolff
Laurence Feldmeyer
Helmut Beltraminelli
Nathalie Bonnet
Florent Amatore
Eve Maubec
Nathalie Franck
Laurent Machet
François Chasset
Florence Brunet-Possenti
Jean-David Bouaziz
Maxime Battistella
Marie Donzel
Anne Pham-Ledard
Claudia Bejar
Hélène Moins-Teisserenc
Samia Mourah
Philippe Saiag
Ewa Hainaut
Catherine Michel
Guido Bens
Henri Adamski
François Aubin
Serge Boulinguez
Pascal Joly
Billal Tedbirt
Isabelle Templier
Laura Troin
Henri Montaudié
Saskia Ingen-Housz-Oro
Sarah Faiz
Laurent Mortier
Gabor Dobos
Martine Bagot
Matthieu Resche-Rigon
Claire Montlahuc
Arnaud Serret-Larmande
Adèle de Masson
author_sort Alizée Bozonnat
collection DOAJ
format Article
id doaj-art-73770a100c944ed8a8857a7a8f8a4f3a
institution Kabale University
issn 2589-5370
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj-art-73770a100c944ed8a8857a7a8f8a4f3a2025-01-22T05:43:14ZengElsevierEClinicalMedicine2589-53702025-01-0179102979Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyAlizée Bozonnat0Marie Beylot-Barry1Olivier Dereure2Michel D’Incan3Gaëlle Quereux4Emmanuella Guenova5Marie Perier-Muzet6Stephane Dalle7Florent Grange8Manuelle-Anne Viguier9Caroline Ram-Wolff10Laurence Feldmeyer11Helmut Beltraminelli12Nathalie Bonnet13Florent Amatore14Eve Maubec15Nathalie Franck16Laurent Machet17François Chasset18Florence Brunet-Possenti19Jean-David Bouaziz20Maxime Battistella21Marie Donzel22Anne Pham-Ledard23Claudia Bejar24Hélène Moins-Teisserenc25Samia Mourah26Philippe Saiag27Ewa Hainaut28Catherine Michel29Guido Bens30Henri Adamski31François Aubin32Serge Boulinguez33Pascal Joly34Billal Tedbirt35Isabelle Templier36Laura Troin37Henri Montaudié38Saskia Ingen-Housz-Oro39Sarah Faiz40Laurent Mortier41Gabor Dobos42Martine Bagot43Matthieu Resche-Rigon44Claire Montlahuc45Arnaud Serret-Larmande46Adèle de Masson47Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, FranceDepartment of Dermatology, CHU de Bordeaux, BoRdeaux Institute of Oncology, BRIC INSERM U1312, INSERM BoRdeaux Institute of Oncology, Team 5, Université de Bordeaux, Bordeaux, FranceDepartment of Dermatology, University of Montpellier, Montpellier, FranceDepartment of Dermatology, CHU de Clermont-Ferrand, Clermont-Ferrand, FranceDepartment of Dermatology, Nantes University Hospital, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, F-44000 Nantes, FranceDepartment of Dermatology, University Hospital Lausanne, Faculty of Biology and Medicine, University of Lausanne, Lausanne, SwitzerlandDepartment of Dermatology, Hospices Civils de Lyon, Lyon, FranceDepartment of Dermatology, Hospices Civils de Lyon, Lyon, FranceDepartment of Dermatology, CH de Valence, FranceDepartment of Dermatology, Université Reims-Champagne Ardenne, EA7509-IRMAIC, Reims, FranceDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandDepartment of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandDepartment of Dermatology, CHU de Marseille, Marseille, FranceDepartment of Dermatology, CHU de Marseille, Marseille, FranceDepartment of Dermatology, Avicenne Hospital, AP-HP, Bobigny, FranceDepartment of Dermatology, CHU Cochin, Paris, FranceDepartment of Dermatology, CHU de Tours, Tours, FranceDepartment of Dermatology, CHU Tenon, Faculty of Medicine, Sorbonne University, Paris, FranceDepartment of Dermatology, CHU Bichat, Paris, FranceDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Pathology Laboratory, Saint-Louis Hospital, AP-HP, Paris, FrancePathology Laboratory, Hospices Civils de Lyon, Lyon, FranceDepartment of Dermatology, CHU de Bordeaux, BoRdeaux Institute of Oncology, BRIC INSERM U1312, INSERM BoRdeaux Institute of Oncology, Team 5, Université de Bordeaux, Bordeaux, FranceDepartment of Dermatology, Avicenne Hospital, AP-HP, Bobigny, FranceUniversité Paris Cité, Paris, France; Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Department of Pharmacogenomics and Oncogenetics, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Dermatology, Ambroise-Paré Hospital, AP-HP, & EA 4340 “Biomarkers in Cancerology and Hemato-Oncology”, UVSQ, Université Paris-Saclay, 92104, Boulogne-Billancourt, FranceDepartment of Dermatology, CHU de Poitiers, Poitiers, FranceDepartment of Dermatology, CH Mulhouse, Groupe Hospitalier Mulhouse Sud Alsace, Mulhouse, FranceDepartment of Dermatology, CHU Orléans, Orléans, FranceDepartment of Dermatology, CHU Pontchaillou, Rennes, FranceDepartment of Dermatology, CHU de Besançon, Besançon, FranceDepartment of Dermatology, CHU de Toulouse, Toulouse, FranceDepartment of Dermatology, CHU de Rouen, Rouen, FranceDepartment of Dermatology, CHU de Rouen, Rouen, FranceDepartment of Dermatology, CHU de Grenoble, Grenoble, FranceDepartment of Dermatology, CHU de Nice, Nice, FranceDepartment of Dermatology, CHU de Nice, Nice, FranceDepartment of Dermatology, Henri Mondor Hospital, APHP, Créteil, FranceDepartment of Dermatology, CHU Lille, Lille, FranceDepartment of Dermatology, CHU Lille, Lille, FranceDepartment of Dermatology, Charité Hospital, Berlin, GermanyDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Corresponding author. Department of Dermatology, National Reference Center for Cutaneous Lymphomas, Saint-Louis Hospital, 1 avenue Claude Vellefaux, F-75010, Paris, France.http://www.sciencedirect.com/science/article/pii/S2589537024005583
spellingShingle Alizée Bozonnat
Marie Beylot-Barry
Olivier Dereure
Michel D’Incan
Gaëlle Quereux
Emmanuella Guenova
Marie Perier-Muzet
Stephane Dalle
Florent Grange
Manuelle-Anne Viguier
Caroline Ram-Wolff
Laurence Feldmeyer
Helmut Beltraminelli
Nathalie Bonnet
Florent Amatore
Eve Maubec
Nathalie Franck
Laurent Machet
François Chasset
Florence Brunet-Possenti
Jean-David Bouaziz
Maxime Battistella
Marie Donzel
Anne Pham-Ledard
Claudia Bejar
Hélène Moins-Teisserenc
Samia Mourah
Philippe Saiag
Ewa Hainaut
Catherine Michel
Guido Bens
Henri Adamski
François Aubin
Serge Boulinguez
Pascal Joly
Billal Tedbirt
Isabelle Templier
Laura Troin
Henri Montaudié
Saskia Ingen-Housz-Oro
Sarah Faiz
Laurent Mortier
Gabor Dobos
Martine Bagot
Matthieu Resche-Rigon
Claire Montlahuc
Arnaud Serret-Larmande
Adèle de Masson
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
EClinicalMedicine
title Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
title_full Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
title_fullStr Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
title_full_unstemmed Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
title_short Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
title_sort real life efficacy of immunotherapy for sezary syndrome a multicenter observational cohort study
url http://www.sciencedirect.com/science/article/pii/S2589537024005583
work_keys_str_mv AT alizeebozonnat reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT mariebeylotbarry reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT olivierdereure reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT micheldincan reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT gaellequereux reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT emmanuellaguenova reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT marieperiermuzet reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT stephanedalle reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT florentgrange reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT manuelleanneviguier reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT carolineramwolff reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT laurencefeldmeyer reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT helmutbeltraminelli reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT nathaliebonnet reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT florentamatore reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT evemaubec reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT nathaliefranck reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT laurentmachet reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT francoischasset reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT florencebrunetpossenti reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT jeandavidbouaziz reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT maximebattistella reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT mariedonzel reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT annephamledard reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT claudiabejar reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT helenemoinsteisserenc reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT samiamourah reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT philippesaiag reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT ewahainaut reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT catherinemichel reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT guidobens reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT henriadamski reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT francoisaubin reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT sergeboulinguez reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT pascaljoly reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT billaltedbirt reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT isabelletemplier reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT lauratroin reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT henrimontaudie reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT saskiaingenhouszoro reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT sarahfaiz reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT laurentmortier reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT gabordobos reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT martinebagot reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT matthieurescherigon reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT clairemontlahuc reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT arnaudserretlarmande reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy
AT adeledemasson reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy